林 慧先生（県立がんセンター）の論文が掲載されました.
Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments After Third-line Nivolumab for Advanced Gastric Cancer.Anticancer Res. 2023 Jun;43(6):2831-2840.
Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments After Third-line Nivolumab for Advanced Gastric Cancer.Anticancer Res. 2023 Jun;43(6):2831-2840.